Thrombolytic therapy with intravenous recombinant tissue plasminogen activator is well established as a beneficial treatment for patients presenting with acute ischemic stroke (AIS). The odds of a favorable clinical outcome (living independently) increase as the time between stroke onset and treatment with...
acute myocardial infarction and pulmonary embolism. The concomitant administration of heparin and aspirin with and following infusions of Activase for the treatment of acute ischemic stroke during the first 24 hours after symptom onset has not been investigated. Because heparin, aspirin, or Activase may...
The initial therapeutic approach to acute ischemic stroke consists of thrombolytic therapy and early initiation of supportive care, usually commenced prior to the determination of the underlying stroke etiology. Varying stroke mechanisms may call for specific, etiology-based treatment. The majority of str...
Ischemic stroke is a common neurological disease. Currently, there are no Food and Drug Administration-approved drugs that can maximize the improvement in ischemic stroke-induced nerve damage. Hence, treating ischemic stroke remains a clinical challenge. Ferroptosis has been increasingly studied in recent...
- 《Stroke》 被引量: 589发表: 2004年 MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized c... Endovascular or intra-arterial treatment (IAT) increases the likelihood of recanalization in patients ...
The treatment of acute ischemic stroke has advanced greatly in the last decade. Currently, intravenous tissue plasminogen activator, intra-arterial recombinant pro-urokinase, and mechanical embolectomy have all been shown to be effective in treating acute ischemic stroke patients. This endovascular treat...
Commentary Treatmentofacuteischemicstrokeinpatientswith cerebralmicrobleeds:adecisionanalysis J.BENBASSAT 1 ,R.BAUMAL 2 andY.HERISHANU 3 Fromthe 1 Myers-JDC-BrookdaleInstitute,theSmoklerCenterforHealthPolicyResearch,Jerusalem, Israel, 2 DepartmentofLaboratoryMedicineandPathobiology,TorontoHospitalforSickChildren...
Comparison of endovascular treatment approaches for acute ischemic stroke: Cost effectiveness, technical success, and clinical outcomes IntroductionThe use of mechanical thrombectomy for the treatment of acute ischemic stroke has significantly advanced over the last 5 years. Few data are... AS Turk,R...
Acute ischemic stroke is the third leading cause of death in the United States and the leading cause of adult disability. The direct and indirect costs of ... LW Barsan - 《Annals of Emergency Medicine》 被引量: 139发表: 2001年 High dose human serum albumin for the treatment of acute isc...
Endovascular Treatment for Acute Ischemic Stroke (MR CLEAN) in the Netherlands, followed by five other positive RCTs, finally established the efficacy of mechanical thrombectomy (MT) with stent retrievers (also called ‘stentrievers’) in AIS due to large vessel occlusion within 6 h of stroke ...